Key Takeaways:
- The Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) issued its opinion in G1/24 on June 18, 2025 resolving divergent case law on how patent claims should be interpreted at the EPO.
- The...more
6/24/2025
/ Appeals ,
Claim Construction ,
EU ,
European Patent Convention ,
European Patent Office ,
Patents ,
Pharmaceutical Patents ,
Statutory Interpretation ,
The Enlarged Board of Appeals ,
UK ,
Unified Patent Court ,
USPTO
Key Takeaways -
- A recent Federal Circuit decision in a case involving an inter partes review (IPR) significantly narrowed a patentee’s ability to rely on estoppel to block a defendant from raising invalidity grounds.
-...more
On October 7, 2024, the Supreme Court declined to hear Cellect LLC v. Vidal, No. 23-1231. The case has been followed closely by patent professionals ever since the Federal Circuit upended the judicially-created doctrine of...more
In December 2021, patent practice was upended by four related United States Patent and Trademark Office (USPTO) Patent Trial & Appeal Board (PTAB) decisions holding that patents subject to statutory Patent Term Adjustment...more
What Congress has guaranteed, the courts have taken away -
The Supreme Court is about to receive a Petition for Certiorari in a case that impacts how long a patent protects new inventions, we expect. Specifically, the case...more
5/16/2024
/ Food and Drug Administration (FDA) ,
Hatch-Waxman ,
Inventions ,
Obviousness-Type Double Patenting (ODP) ,
Patent Term Adjustment ,
Patent Trial and Appeal Board ,
Patents ,
Petition for Writ of Certiorari ,
Popular ,
SCOTUS ,
USPTO